Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.Brainstorm Cell Therapeutics Inc.

Brainstorm Cell Therapeutics Inc.

No trades
See on Supercharts

Price target

10.000.000.00%
The 1 analyst offering 1 year price forecasts for BCLI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 1 analyst giving stock ratings to BCLI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


BCLI EPS for the last quarter is 0.60 USD despite the estimation of −0.53 USD. In the next quarter EPS is expected to reach −0.57 USD. Track more of Brainstorm Cell Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Brainstorm Cell Therapeutics Inc. revenue is expected to reach 0.00 USD. Check out Brainstorm Cell Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, BCLI price target is 10.00 USD with a max estimate of 10.00 USD and a min estimate of 10.00 USD. Check if this forecast comes true in a year, meanwhile watch Brainstorm Cell Therapeutics Inc. stock price chart and keep track of the current situation with BCLI news and stock market news.